“…It is often underdiagnosed (Peppard et al, 2013), though its prevalence is increasing and was recently shown to be up to 40% in the general population (Heinzer et al, 2015), and likely higher in the elderly population (Al Lawati et al, 2009;Heinzer et al, 2015). SAS interrupts sleep and causes intermittent hypoxia (Rosenzweig et al, 2015) which could contribute to a range of pathophysiological consequences, including cognitive impairment (Wallace and Bucks, 2013;Arli et al, 2015), particularly in older patients (Yaffe et al, 2011;Osorio et al, 2015;Tsapanou et al, 2018). In fact, SAS is more prevalent in patients suffering from neurodegenerative diseases (Moran et al, 2005;Emamian et al, 2016) and is suspected to increase risks of developing Alzheimer's disease (Aoki et al, 2014;Osorio et al, 2015;Liguori and Placidi, 2018).…”